Fundz

Synakis Corp. closes CAD $2.6 million oversubscribed pre-seed round to advance its vitreous replacement therapy SNK-125, co-led by TIAP and Chiefswood.

PRIVATEMay 21, 2026

Amount Raised

C$2.6 Million

Round Type

Pre-Seed

TorontoBiotechnologyHealth Care

Investors

Ontario Centre Of InnovationCanadian Glycomics NetworkToronto Innovation Acceleration PartnersChiefswood Private Capital Inc.

Description

Synakis Corp. has successfully closed a CAD $2.6 million oversubscribed pre-seed financing round to support its ocular therapy development. The funds will be used for GLP toxicology studies and lead optimization for SNK-125. The round was co-led by Toronto Innovation Acceleration Partners and Chiefswood Private Capital, with support from OCI and GlycoNet

Quick answer

Synakis raised C$2.6 Million in a Pre-Seed round, dated May 21, 2026. Investors: Ontario Centre Of Innovation, Canadian Glycomics Network, Toronto Innovation Acceleration Partners and Chiefswood Private Capital Inc. Synakis is based in Toronto, Ontario, Canada.

How much did Synakis raise?
Synakis raised C$2.6 Million in a Pre-Seed round on May 21, 2026.
Who invested in Synakis?
Ontario Centre Of Innovation, Canadian Glycomics Network, Toronto Innovation Acceleration Partners and Chiefswood Private Capital Inc. are named as investors in this round.
What does Synakis do?
Synakis is a Toronto-based pre-clinical biotechnology company developing ocular products to preserve vision through its proprietary platform technology.
Where is Synakis based and how big is it?
Synakis is based in Toronto, Ontario, Canada. Fundz records about 4 employees.
Who are the decision-makers at Synakis?
Fundz holds 1 contact at Synakis, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Synakis that raised within 45 days of this round, from Fundz verified event records.

  • Axten Hospitals raised $262K (Seed) on July 5, 2026.
  • LigaChem Biosciences raised $357M (Post-IPO Equity) on July 4, 2026.
  • ARIBIO raised $28M (Corporate Round) on July 3, 2026.
  • Gestala Technology raised $66M (Angel) on July 3, 2026.
  • NewcelX raised $2.9M on July 3, 2026.
  • Rosota raised $965K (Seed) on July 2, 2026.

Who to call at Synakis, and when

A new round usually means Synakis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Synakis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synakis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synakis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synakis

Location

Toronto, Ontario, Canada

About

Synakis is a Toronto-based pre-clinical biotechnology company developing ocular products to preserve vision through its proprietary platform technology. The company is developing products for retinal diseases, retinal detachment, and glaucoma. Synakis was spun out of the laboratory of Professor Molly Shoichet at the University of Toronto.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synakis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsThierry N., Chief Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Synakis's next move

See what Strategic adds

Synakis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.